Shanga Saieed: It Was An Absolute Pleasure to Be Part of The Hemostasis Advanced Training
Shanga Saieed, Product Manager at Mediq, reposted from Daria Prokudina on LinkedIn:
”Thank you so much for the inspiring and truly valuable training session.
It was an absolute pleasure to be part of the Hemostasis Advanced Training.
Your passion, deep knowledge, and engaging teaching style made the learning experience exceptional.
I really appreciate the effort and dedication you both put into creating such a meaningful and interactive program.
I’m leaving the training feeling motivated, more confident, and eager to apply what I’ve learned in my daily work.
Thank you once again for sharing your expertise and for making the sessions so enjoyable and insightful.”
Quoting Daria Prokudina‘s post:
”Last week, my dear colleague Valentina Crippa and I had the privilege of hosting a pilot project: Hemostasis Advanced Training.
This initiative is part of our ongoing commitment to elevating the education process across EEMEA.
The advanced training was specifically designed to dive deeper into topics that we couldn’t cover during the first-level basic program.
A heartfelt thank you to all our participants – your expertise and dedication truly made you co-creators of this event.
It was a genuine pleasure to spend this time with such passionate professionals.
I hope the new knowledge you gained will empower you to better support your customers in the field of hemostasis and boost your confidence in tackling complex topics.
Wishing everyone continued success on your professional journeys!”
Stay updated with Hemostasis Today.
-
Oct 21, 2025, 06:59Samwel Mikaye: Polycythemia and the Risk of Blood Clots
-
Oct 21, 2025, 06:58Samuel Nweke: Interpreting D-Dimer Results
-
Oct 21, 2025, 05:20Ewa Fiorentino Rozek: APS - When “Unprovoked” Clots And Pregnancy Loss Connect
-
Oct 21, 2025, 03:503 Questions With Abigail Ajanel Gomez – Touch Haematology Future Leader 2025
-
Oct 21, 2025, 01:57Mohamed Reda: Clotting Factors — The Key Players in Blood Coagulation
-
Oct 22, 2025, 10:35Evaluating a Novel Human Fibrinogen Concentrate (BT524) for Congenital Fibrinogen Deficiency
-
Oct 22, 2025, 09:37Jurjen Krommenhoek and Colleagues Propose a Clinical Care Pathway for Major Bleeding Survivors
-
Oct 22, 2025, 09:32Ishac Nazy: Proud Moment For Our Team!
-
Oct 22, 2025, 09:16Richard Benjamin Shares Results of The ReCePI Phase III Clinical Study
-
Oct 21, 2025, 11:13Hanny Al Samkari's Commentary on Iron Deficiency Anemia in Inherited Bleeding Disorders
-
Oct 22, 2025, 08:25Johanna Nystedt: Not Every Day We Can Release a New Blood Product to Meet An Unmet Medical Need!
-
Oct 21, 2025, 06:58Arno Nierich: How Caffeine Affects Red Blood Cells and Blood Storage
-
Oct 21, 2025, 06:43Could Gene Therapy Offer Lasting Quality of Life for People with Hemophilia B?
-
Oct 21, 2025, 06:18Katerina Akassoglou Receives Zenith Fellows Award to Advance Alzheimer’s Research
-
Oct 16, 2025, 06:07ClearPlasma - A New Breakthrough in Stopping Life-Threatening Bleeds
-
Oct 22, 2025, 10:46Conversation with Ferran Nadeu – Touch Haematology Future Leader 2025
-
Oct 22, 2025, 10:32Lynn Malec - The New Director of the CCBD and Pharmacy at Children's Wisconsin
-
Oct 22, 2025, 09:41Deanna Joseph: Feeling Inspired and Deeply Grateful After Attending the 2025 HTRS SEARCH Workshop
-
Oct 22, 2025, 08:41Maryum Salim Reflects on Her Experience at the HTRS SEARCH Workshop
-
Oct 22, 2025, 08:36Emilya Huseynova to Speak at AABB 2025